Silo Pharma, Inc. (SILO) — Institutional Holders, Q2 2026
9 institutional investment managers reported a SILO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $886.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SILO 13F holders ranked 1–9 of 9
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | AdvisorShares Investments#1 · 75,582 sh | 75,582 | $469.4K | 0.06% | -88.6% |
| 2 | FNY Investment Advisers#2 · 37,507 sh | 37,507 | $232.0K | — | New |
| 3 | CITADEL ADVISORS#3 · 16,800 sh | 16,800 | $104.3K | 0.00% | -21.7% |
| 4 | VANGUARD CAPITAL MANAGEMENT#4 · 11,956 sh | 11,956 | $74.2K | 0.00% | +6.6% |
| 5 | VANGUARD FIDUCIARY#5 · 874 sh | 874 | $5.4K | 0.00% | -93.3% |
| 6 | Tower Research Capital (TRC)#6 · 181 sh | 181 | $1.1K | 0.00% | -89.2% |
| 7 | HARBOUR INVESTMENTS#7 · 14 sh | 14 | $87.00 | 0.00% | New |
| 8 | IFP Advisors#8 · 175 sh | 175 | $61.00 | — | 0.0% |
| 9 | CITIGROUP#9 · 1 sh | 1 | $6.00 | 0.00% | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.